BPA for kimmtrak
Active Awarded Last action
- Contract number
- 36E79725A0014
- Awardee
-
Immunocore Commercial LLC UEI FZLMFD51RYN1
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 78% complete
- IDV ceiling
- $4,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded a single-award Blanket Purchase Agreement valued at $4,000,000 to Immunocore Commercial LLC for the supply of KIMMTRAK (tebentafusp-tebn), a 100 micrograms per 0.5 milliliter injectable pharmaceutical product indicated for hematology-related treatments. This BPA, issued on April 10, 2025, with an ultimate completion date of April 9, 2027, was awarded without a small business set-aside and represents an exercise option year renewal of the existing agreement (36E79725A0014). The contract falls under Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs) and leverages the National Acquisition Center's procurement authority to supply specialized pharmaceutical products to federal healthcare systems, particularly the Department of Veterans Affairs and its regional Veterans Integrated Service Networks.
Immunocore Commercial LLC, a foreign-owned pharmaceutical manufacturer registered in the System for Award Management, has demonstrated consistent capability in supplying KIMMTRAK to the Veterans Affairs healthcare system through multiple prior contract vehicles, including a $225,000 Federal Supply Schedule multiple-award contract and previous interim agreements. The expansion of the Blanket Purchase Agreement ceiling to $4,000,000 reflects increased demand for this specialized pharmaceutical product across the VA's distributed healthcare network. Under this IDV, the National Acquisition Center will issue firm fixed-price delivery orders to support pharmaceutical supply requirements across Veterans Integrated Service Networks, enabling healthcare facilities to maintain adequate inventory of this specialized therapeutic agent for eligible patient populations requiring hematology-related treatment protocols.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0014?
36E79725A0014 was awarded to Immunocore Commercial LLC by National Acquisition Center (Headquarters) on April 10, 2025.
How much is contract 36E79725A0014 worth?
36E79725A0014's own ceiling is $4,000,000.
Who can order from contract 36E79725A0014?
36E79725A0014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0014 under another contract?
Yes. 36E79725A0014 is a blanket purchase agreement under 36F79724D0026, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79725A0014 competed?
The extent of competition for 36E79725A0014 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV